India — Private Investments Scaling Up in Clinical Trial Industry

Clinical trials are considered as one of the most important stages of the drug development and share a major part of the cost and time involved in the whole process. With an increasing pressure on pharmaceutical and biotech companies to increase their product pipelines and at the same time to reduce the cost involved in drug development, multinational pharmaceutical companies have started outsourcing clinical trials to emerging healthcare markets like India. RNCOS, a leading market research firm, says in its new report «Booming Clinical Trials Market in India» that India has tremendous potential to attract multinationals to invest in its clinical trials market. The market is expected to grow at a CAGR of around 31% during 2010-2012.

With the increasing trend of outsourcing clinical trials, the private investments in the sector have also increased. Most of these investments are aimed at setting up clinical trial facilities in the country. Also, it has been observed that some multinationals have made joint ventures with the Indian companies to set up such facilities. In this regard, our research report provides complete information on the current scenario of the Indian clinical trial industry.

One of the other major advantages that India has, is the availability of large patient pool. The prevalence of diseases, like CVD, diabetes and cancer, is very high in the country, and this makes the availability and administration of patients for clinical trials very easy. Our research provides a thorough study and analysis of the Indian clinical trial industry. Besides, the report has also highlighted the importance of cost factor in the development of the industry and it provides complete details of the cost involved in various phases of clinical trials in the country.

«Booming Clinical Trials Market in India» gives a comprehensive review of the Indian clinical trial industry. Thorough evaluation of current trends and developments vital for the success of Indian clinical trials market has been done. The report also covers information on various major players present in the market. The report will prove to be a useful investment guide for our clients who are looking forward to invest in the market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com